Monday’s ruling by the U.S. Court of Appeals for the Second Circuit could revive nearly 600 lawsuits tying Tylenol to autism and ADHD.
Monday’s ruling by the U.S. Court of Appeals for the Second Circuit could revive nearly 600 lawsuits tying Tylenol to autism and ADHD.

